199 related articles for article (PubMed ID: 25024622)
1. Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.
Ma H; Hasim A; Mamtimin B; Kong B; Zhang HP; Sheyhidin I
World J Gastroenterol; 2014 Jul; 20(26):8653-9. PubMed ID: 25024622
[TBL] [Abstract][Full Text] [Related]
2. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
[TBL] [Abstract][Full Text] [Related]
3. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
4. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
[TBL] [Abstract][Full Text] [Related]
6. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F
Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma.
Zhao H; Chen W; Wu J; Wang L; Mao W
J Cancer Res Ther; 2014 Nov; 10 Suppl():C179-85. PubMed ID: 25450279
[TBL] [Abstract][Full Text] [Related]
9. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
10. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
Li SP; Su HX; Zhao D; Guan QL
Med Sci Monit; 2016 Jun; 22():2195-201. PubMed ID: 27345473
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
12. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
Jiao XL; Chen D; Wang JG; Zhang KJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
[TBL] [Abstract][Full Text] [Related]
14. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
15. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
Wu C; Li M; Hu C; Duan H
Mol Biol Rep; 2014 Mar; 41(3):1257-66. PubMed ID: 24390317
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
[TBL] [Abstract][Full Text] [Related]
18. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
[TBL] [Abstract][Full Text] [Related]
20. Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach.
Zhang Y; Wang J; Dai N; Han P; Li J; Zhao J; Yuan W; Zhou J; Zhou F
BMC Cancer; 2020 Sep; 20(1):835. PubMed ID: 32878621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
